Skip to content
MedsAcross

Medicine

Acyclovir 5% ointment

Acyclovir · Cutaneous
Available on requestPrescription onlyUS FDAGeneric name

Acyclovir 5% ointment is a generic prescription medicine for cutaneous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 15° to 25°C (59° to 77°F). Store in a dry place Call your doctor for…

Key facts

Active ingredient (INN)
Acyclovir
Brand
Sold under the generic name
Strength
5%
Dosage form
Ointment
Route
Cutaneous
Packs
1 tube
Manufacturer
Alembic PharmaceuticalsIndia
Origin register
US FDA, United States
Storage
Store at 15° to 25°C (59° to 77°F). Store in a dry place Call your doctor for medical advice about side effects.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
D06BB03 Acyclovir
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
27 March 2025
Identifiers
RxCUI 197312DailyMed set ID 5adf2205-5493-4e7a-bf50-01f4eb661dd8NDC 62332-248Application ANDA209000

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 tube in 1 carton / 5 g in 1 tube62332-248-05Alembic PharmaceuticalsIndia27 March 2025
1 tube in 1 carton / 15 g in 1 tube62332-248-15Alembic PharmaceuticalsIndia27 March 2025
1 tube in 1 carton / 30 g in 1 tube62332-248-30Alembic PharmaceuticalsIndia27 March 2025
1 tube in 1 carton / 15 g in 1 tube68462-746-17—31 July 2017
1 tube in 1 carton / 30 g in 1 tube68462-746-35—31 July 2017
1 tube in 1 carton / 15 g in 1 tube33342-439-15—5 August 2021
1 tube in 1 carton / 30 g in 1 tube33342-439-30—13 August 2018
1 tube in 1 carton / 15 g in 1 tube51672-1360-1—21 December 2016
1 tube in 1 carton / 30 g in 1 tube51672-1360-2—21 December 2016
1 tube in 1 carton / 5 g in 1 tube51672-1360-5—4 December 2024
15 g in 1 tube13668-515-01—11 January 2019
30 g in 1 tube13668-515-02—11 January 2019
1 tube in 1 carton / 15 g in 1 tube72578-082-01—8 June 2020
1 tube in 1 carton / 30 g in 1 tube72578-082-06—8 June 2020
1 tube in 1 carton / 15 g in 1 tube70771-1371-1—21 March 2019
1 tube in 1 carton / 30 g in 1 tube70771-1371-2—21 March 2019
1 tube in 1 carton / 15 g in 1 tube65162-835-94—3 January 2014
1 tube in 1 carton / 30 g in 1 tube65162-835-96—3 January 2014
2 tube in 1 carton / 5 g in 1 tube85957-036-01—10 April 2026
1 tube in 1 carton / 15 g in 1 tube85957-036-02—10 April 2026
1 tube in 1 carton / 30 g in 1 tube85957-036-03—10 April 2026
15 g in 1 tube68788-4142-1—12 August 2026
1 tube in 1 carton / 30 g in 1 tube43547-499-41—15 November 2021
1 tube in 1 carton / 15 g in 1 tube43547-499-42—15 November 2021
1 tube in 1 carton / 15 g in 1 tube70700-107-15—30 January 2020
1 tube in 1 carton / 30 g in 1 tube70700-107-16—30 January 2020
30 g in 1 tube63629-2327-1—19 April 2021
15 g in 1 tube63629-2328-1—19 April 2021
15 g in 1 tube72162-1960-2—25 January 2024
30 g in 1 tube72162-1960-3—25 January 2024
1 tube in 1 carton / 15 g in 1 tube50090-6561-0—18 July 2023
1 tube in 1 carton / 15 g in 1 tube50090-8074-0—15 September 2026
1 tube in 1 carton / 15 g in 1 tube16714-885-01—31 December 2018
1 tube in 1 carton / 30 g in 1 tube16714-885-02—31 December 2018
1 tube in 1 carton / 15 g in 1 tube68071-3909-5—23 October 2025
1 tube in 1 carton / 15 g in 1 tube68788-8247-1—19 August 2022
1 tube in 1 carton / 15 g in 1 tube85766-115-15—31 October 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 29 March 1982Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Acyclovir 5% ointment.

Compare all 2

Other strengths and forms of Acyclovir

Clinical summary

Acyclovir is a herpes simplex virus nucleoside analog DNA polymerase inhibitor indicated in the management of initial genital herpes and in limited non-lifethreatening mucocutaneous HSV infections in immunocompromised patients. MedsAcross supplies Acyclovir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Acyclovir

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Acyclovir 5% ointment for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.